Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
91
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma

Hongmei ZhengDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Yuting ZhangDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Yuting ZhanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Sile LiuDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Junmi LuDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Juan FengDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Xia WuDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
,
Qiuyuan WenDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of China
&
Songqing FanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 6139-6150 | Published online: 04 Jul 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tarfah Al-Warhi, Ahmed A. Al-Karmalawy, Ayman Abo Elmaaty, Maha A. Alshubramy, Marwa Abdel-Motaal, Taghreed A. Majrashi, Medhat Asem, Ahmed Nabil, Wagdy M. Eldehna & Marwa Sharaky. (2023) Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 176-191.
Read now
Yu-Hung Fang, Yao-Hsu Yang, Meng-Jer Hsieh, Ming-Szu Hung & Yu-Ching Lin. (2019) Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study. Cancer Management and Research 11, pages 8539-8546.
Read now

Articles from other publishers (9)

Xingxiang Pu, Zemin Xiao, Jia Li, Zhijun Wu, Zhongxia Ma, Jie Weng, Maoliang Xiao, Yanhua Chen, Yongqing Cao, Peiguo Cao, Qianzhi Wang, Yan Xu, Kang Li, Bolin Chen, Fang Xu, Liyu Liu, Yi Kong, Hui Zhang, Huaxin Duan & Lin Wu. (2024) Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial. Lung Cancer 191, pages 107538.
Crossref
Yuan Cheng, Huan Wang, Wendi Yuan, Haotian Wang, Yuheng Zhu, Huanhuan Chen & Wenyan Jiang. (2023) Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC. Physica Medica 116, pages 103177.
Crossref
Bin Xie, Xi Chen, Qi Deng, Ke Shi, Jian Xiao, Yong Zou, Baishuang Yang, Anqi Guan, Shasha Yang, Ziyu Dai, Huayan Xie, Shuya He & Qiong Chen. (2022) Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study. Journal of Healthcare Engineering 2022, pages 1-13.
Crossref
Ying Fan, Yue Dong, Xinyan Sun, Huan Wang, Peng Zhao, Hongbo Wang & Xiran Jiang. (2022) Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases. BMC Cancer 22:1.
Crossref
Ran Cao, Yue Dong, Xiaoyu Wang, Meihong Ren, Xingling Wang, Nannan Zhao, Tao Yu, Lu Zhang, Yahong Luo, E-Nuo Cui & Xiran Jiang. (2022) MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma. Academic Radiology 29:3, pages e9-e17.
Crossref
Jiangdian Song, Changwei Ding, Qinlai Huang, Ting Luo, Xiaoman Xu, Zongjian Chen & Shu Li. (2021) Deep learning predicts epidermal growth factor receptor mutation subtypes in lung adenocarcinoma. Medical Physics 48:12, pages 7891-7899.
Crossref
Naiqun Wang, Xiaolian Zhang, Feilong Wang, Min Zhang, Bo Sun, Weihua Yin, Shaorong Deng, Ying Wan & Wei Lu. (2021) The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies. SLAS Technology 26:1, pages 42-54.
Crossref
Shu Li, Ting Luo, Changwei Ding, Qinlai Huang, Zhihao Guan & Hao Zhang. (2020) Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning. Medical Physics 47:8, pages 3458-3466.
Crossref
Guiping Wang, Yingying Zhong, Jiecong Liang, Zhibin Li & Yun Ye. (2020) Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma. PeerJ 8, pages e8625.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.